Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
MYCOPHENOLATE ACCORD, MYCOPHENOLATE INTAS (Accord Healthcare Pty Ltd)
Product name
MYCOPHENOLATE ACCORD, MYCOPHENOLATE INTAS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
137 (255 working days)
Active ingredients
mycophenolate mofetil
Registration type
New generic medicine
Indication
MYCOPHENOLATE ACCORD, MYCOPHENOLATE INTAS (powder for injection) is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.
MYCOPHENOLATE ACCORD, MYCOPHENOLATE INTAS is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.